IGF1 and breast carcinoma: Although evidence suggest that carrying a BRCA mutation could be a potential confounder of the association between IGF-1 serum concentration and BC risk53, 54, we did not exclude women with these mutations, because we have this information only for the MBCS women with breast cancer and not for controls.